Cite
MLA Citation
Ruoshi Shi et al.. “BRAF V600E mutation and MET amplification as resistance pathways of the second-generation anaplastic lymphoma kinase (ALK) inhibitor alectinib in lung cancer.” Lung cancer, vol. 146, 2020, pp. 78–85. http://access.bl.uk/ark:/81055/vdc_100105148159.0x000053